William O. Sandals

Array ( [id] => 4213692 [patent_doc_number] => 06110736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Site-directed recombination in plants' [patent_app_type] => 1 [patent_app_number] => 9/211408 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 13922 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110736.pdf [firstpage_image] =>[orig_patent_app_number] => 211408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326220 [patent_doc_number] => 06599698 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/209981 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10448 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599698.pdf [firstpage_image] =>[orig_patent_app_number] => 09209981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340387 [patent_doc_number] => 06586204 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Apoptosis gene EI24, compositions, and methods of use' [patent_app_type] => B2 [patent_app_number] => 09/151771 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20889 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586204.pdf [firstpage_image] =>[orig_patent_app_number] => 09151771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1458690 [patent_doc_number] => 06391547 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Microbial -glucuronidase genes, gene products and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/149727 [patent_app_country] => US [patent_app_date] => 1998-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23280 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391547.pdf [firstpage_image] =>[orig_patent_app_number] => 09149727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256073 [patent_doc_number] => 06203982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Method for screening compounds regulating the expression of human-inducible nitric oxide synthase' [patent_app_type] => 1 [patent_app_number] => 9/068880 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 7929 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/203/06203982.pdf [firstpage_image] =>[orig_patent_app_number] => 068880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4195878 [patent_doc_number] => 06013453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Binding proteins for recognition of DNA' [patent_app_type] => 1 [patent_app_number] => 9/139762 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 24882 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013453.pdf [firstpage_image] =>[orig_patent_app_number] => 139762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241224 [patent_doc_number] => 06683047 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Method of inhibiting transcription utilizing nuclear receptors' [patent_app_type] => B1 [patent_app_number] => 09/139525 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3357 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683047.pdf [firstpage_image] =>[orig_patent_app_number] => 09139525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4247747 [patent_doc_number] => 06207377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Method for construction of thermus-E. coli shuttle vectors and identification of two Thermus plasmid replication origins' [patent_app_type] => 1 [patent_app_number] => 9/134246 [patent_app_country] => US [patent_app_date] => 1998-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 4558 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207377.pdf [firstpage_image] =>[orig_patent_app_number] => 134246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086085 [patent_doc_number] => 06133038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Platinum-containing compounds methods for their preparation and applications thereof' [patent_app_type] => 1 [patent_app_number] => 9/131625 [patent_app_country] => US [patent_app_date] => 1998-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13089 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133038.pdf [firstpage_image] =>[orig_patent_app_number] => 131625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937537 [patent_doc_number] => 05929302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Plant tissue/stage specific promoters for regulated expression of transgenes in plants' [patent_app_type] => 1 [patent_app_number] => 9/111573 [patent_app_country] => US [patent_app_date] => 1998-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 16225 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929302.pdf [firstpage_image] =>[orig_patent_app_number] => 111573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1476547 [patent_doc_number] => 06451256 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine' [patent_app_type] => B1 [patent_app_number] => 09/043187 [patent_app_country] => US [patent_app_date] => 1998-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4086 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451256.pdf [firstpage_image] =>[orig_patent_app_number] => 09043187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419519 [patent_doc_number] => 06225112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Human p27Kip1 gene promoter' [patent_app_type] => 1 [patent_app_number] => 9/103510 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7297 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225112.pdf [firstpage_image] =>[orig_patent_app_number] => 103510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944981 [patent_doc_number] => 05981837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Method for regulation of plant lignin composition' [patent_app_type] => 1 [patent_app_number] => 9/091432 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 8 [patent_no_of_words] => 11678 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981837.pdf [firstpage_image] =>[orig_patent_app_number] => 091432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101282 [patent_doc_number] => 06051400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Patched-2 polypeptides and polynucleotides' [patent_app_type] => 1 [patent_app_number] => 9/082267 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10887 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051400.pdf [firstpage_image] =>[orig_patent_app_number] => 082267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433285 [patent_doc_number] => 06340575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity' [patent_app_type] => B1 [patent_app_number] => 09/079812 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 16371 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340575.pdf [firstpage_image] =>[orig_patent_app_number] => 09079812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375217 [patent_doc_number] => 06303300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Poly (organo) phosphazenes for use in synthetic transfection systems' [patent_app_type] => 1 [patent_app_number] => 9/076899 [patent_app_country] => US [patent_app_date] => 1998-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4878 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303300.pdf [firstpage_image] =>[orig_patent_app_number] => 076899 [rel_patent_id] =>[rel_patent_doc_number] =>)